Voltage-dependent large-conductance Ca 2+ -activated K + channels, often referred to as BK channels, are a unique class of ion channels coupling intracellular chemical signaling to electrical signaling. BK channel expression has been shown to be up-regulated in human glioma biopsies, and expression levels correlate positively with the malignancy grade of the tumor. Glioma BK channels (gBK) are a splice variant of the hslo gene, are characterized by enhanced sensitivity to [Ca 2+ ] i , and are the target of modulation by growth factors. By using the selective pharmacological BK channel inhibitor iberiotoxin, we examined the potential role of these channels in tumor growth. Cell survival assays examined the ability of glioma cells to grow in nominally serum-free medium. Under such conditions, BK channel inhibition by iberiotoxin caused a dose-and time-dependent decrease in cell number discernible as early as 72 hr after exposure and maximal growth inhibition after 4-5 days. FACS analysis shows that IbTX treatment arrests glioma cells in S phase of the cell cycle, whereupon cells undergo cell death. Interestingly, IbTX effects were nullified when cells were maintained in 7% fetal calf serum. Electrophysiological analysis, in conjunction with biotinylation studies, demonstrates that serum starvation caused a significant translocation of BK channel protein to the plasma membrane, corresponding to a two-to threefold increase in whole-cell conductance, but without a change in total gBK protein. Hence, expression of functional gBK channels appears to be regulated in a growth-factor-dependent manner, with enhanced surface expression promoting tumor cell growth under conditions of growth factor deprivation as might occur under in vivo conditions. Keywords BK channel; glioma; proliferation; iberiotoxin; cell growth Gliomas are primary brain tumors believed to originate from normal glial cells or their progenitors. They account for 20% of all brain malignancies and are characterized by relentless growth and aggressive invasion into the brain parenchyma. These features make surgical treatment of these cancers difficult, resulting in a dim prognosis for affected patients. Much has been learned regarding the unusual growth characteristics of gliomas. Most notably, it has been demonstrated that these tumors can grow under conditions that would be adverse to growth of nonmalignant cells (Rouzaire-Dubois et al., 1993). Thus, whereas normal cell growth depends on the continuous presence of growth factors, glioma cells have developed autocrine and paracrine signaling cascades that support their growth in the absence of exogenous growthstimulating factors (Rozengurt, 1999;Heasley, 2001;Gerber and Ferrara, 2003;Yu et al., 2003). Such factors include, for example, neuregulin-1, which is synthesized and released by , 1997) and which signals through heterodimeric erb-B2/erb-B4 receptors that are overexpressed in glioma cells (Westphal et al., 1997). In at least 50% of human gliomas, the epidermal growth factor receptor (EGF-R...